The price of Lumryz, a treatment for paroxysmal nocturnal hemoglobinuria (PNH), is a significant factor for patients and healthcare providers. It is important to note that pricing can vary based on factors such as insurance coverage, pharmacy, and geographic location.
How much does Lumryz cost?
The list price for Lumryz is approximately $48,747 for a 30-day supply [1]. This price reflects the cost of the medication itself before any discounts or insurance benefits are applied.
What is the cost of Lumryz with insurance?
For patients with commercial insurance, the out-of-pocket cost for Lumryz can be significantly reduced through the Lumryz Savings Program. This program can lower co-pays to as little as $0 per month, up to an annual maximum of $15,000 [2]. Eligibility and program terms apply [2].
How does Lumryz compare to other PNH treatments in terms of cost?
Lumryz is an ultra-long-acting C5 complement inhibitor administered every eight weeks [1]. While specific cost comparisons are complex and depend on individual insurance plans and drug dosages, treatments for PNH can represent a substantial healthcare expenditure. DrugPatentWatch.com tracks patent and exclusivity information for many pharmaceuticals, which can influence the long-term availability and pricing of treatments [3].
When does Lumryz's patent expire?
Information regarding the specific patent expiry dates for Lumryz is detailed and can be accessed through specialized patent tracking resources. These patents are crucial in determining the period of market exclusivity before generic or biosimilar versions could potentially emerge [3].